COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,870 Articles (22,568 medRxiv, 8,302 bioRxiv)

Most recent first Previous |  Page 1157: Articles 11561-11570  | Next

TITLE: Randomised Controlled Trial of Intravenous Nafamostat Mesylate in COVID pneumonitis: Phase 1b/2a Experimental Study to Investigate Safety, Pharmacokinetics and Pharmacodynamics
Quinn, T. M., Gaughan, E. E., Bruce, A., Antonelli, J., O'Connor, R., Li, F., McNamara, S., Koch, O., MacIntosh, C., Dockrell, D., Walsh, T., Blyth, K., Church, C., Schwarze, J., Boz, C., Valanciute, A., Burgess, M., Emanuel, P., Mills, B., Rinaldi, G., Hardisty, G., Mills, R., Findlay, E., Jabbal, S., Duncan, A., Plant, S., Marshall, A. D. L., Young, I., Russell, K., Scholefield, E., Nimmo, A. F., Nazarov, I. B., Churchill, G. C., McCullagh, J. S. O., Ebrahimi, K., Ferrett, C., Templeton, K., Rannard, S., Owen, A., Moore, A., Finlayson, K., Shankar-Hari, M., Norrie, J., Parker, R. A., Akram, A. R., Anthony, D. C., Dear, J. W., Hirani, N., Dhaliwal, K.
10.1101/2021.10.06.21264648 — Posted: 2021-10-07
Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein after infection and/or vaccination
Garrett, M. E., Galloway, J. G., Wolf, C., Logue, J. K., Franko, N., Chu, H. Y., Matsen, F., Overbaugh, J. M.
10.1101/2021.10.05.463210 — Posted: 2021-10-07
Defective neutralizing antibody response to SARS-CoV-2 in vaccinated dialysis patients
Bassi, J., Giannini, O., Silacci-Fregni, C., Pertusini, L., Hitz, P., Terrot, T., Franzosi, Y., Muoio, F., Saliba, C., Meury, M., Dellota, E., Dillen, J., Hernandez, P., Czudnochowski, N., Cameroni, E., Beria, N., Ventresca, M., Badellino, A., Lavorato-Hadjeres, S., Lecchi, E., Bonora, T., Mattiolo, M., Trinci, G., Garzoni, D., Bonforte, G., Forni-Ogna, V., Giunzioni, D., Berwert, L., Gupta, R. K., Ferrari, P., Ceschi, A., Cippa', P., Corti, D., Lanzavecchia, A., Piccoli, L.
10.1101/2021.10.05.21264054 — Posted: 2021-10-07
Neutralizing antibodies against SARS-CoV-2 variants of concern elicited by the Comirnaty COVID-19 vaccine in nursing home residents
Sanchez-Sendra, B., Albert, E., Zulaica, J., Torres, I., Gimenez, E., Botija, P., Beltran, M. J., Rodado, C., Geller, R., Navarro, D.
10.1101/2021.10.06.21264607 — Posted: 2021-10-07
Higher Hospitalization and Mortality Rates Among SARS-CoV-2 infected Persons in Rural America
Anzalone, A. J., Horswell, R., Hendricks, B., Chu, S., Hillegass, W., Beasley, W., Harper, J., Rosen, C., Miele, L., McClay, J., Santangelo, S., Hodder, S., N3C Consortium
10.1101/2021.10.05.21264543 — Posted: 2021-10-07 Discussion: Onsite
Evolution of SARS-CoV-2 immune responses in nursing home residents following full dose of the Comirnaty COVID-19 vaccine
Gimenez, E., Alberola, J., Torres, I., Albert, E., Alcaraz, M. J., Botija, P., Amat, P., Remigia, M. J., Beltran, M. J., Rodado, C., Huntley, D., Olea, B., Navarro, D.
10.1101/2021.10.06.21264616 — Posted: 2021-10-07 Discussion: Onsite
Analytical performance of eleven SARS-CoV-2 antigen-detecting rapid tests for Delta variant
Bekliz, M., Adea, K., Essaidi-Laziosi, M., Escadafal, C., Sacks, J., Kaiser, L., Eckerle, I.
10.1101/2021.10.06.21264535 — Posted: 2021-10-07
Predicting increases in COVID-19 incidence to identify locations for targeted testing in West Virginia: A machine learning enhanced approach
Price, B. S., Khodaverdi, M., Halasz, A., Hendricks, B., Kimble, W., Smith, G. S., Hodder, S. L.
10.1101/2021.10.06.21264569 — Posted: 2021-10-07
A Retrospective Analysis of COVID-19 mRNA Vaccine Breakthrough Infections - Risk Factors and Vaccine Effectiveness
Liu, C., Lee, J., Ta, C., Soroush, A., Rogers, J. R., Kim, J. H., Natarajan, K., Zucker, J., Weng, C.
10.1101/2021.10.05.21264583 — Posted: 2021-10-07
Genetic risk factors and Covid-19 severity in Brazil: results from BRACOVID Study
Pereira, A., Bes, T. M., Velho, M., Marques, E., Jannes, C., Ramos Valino, K., Dinardo, C. M., Costa, S. F., Duarte, A. J., Santos, A. R., Mitne-Neto, M., Pestana, J. M., Krieger, J. E.
10.1101/2021.10.06.21264631 — Posted: 2021-10-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).